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iperacillin/tazobactam and ciproﬂoxacin. Ninety percent of tested
solates were resistant to amikacin, gentamicin, netilmicin and
obramycin, but 80% were still susceptible to colistin. The MIC
anges for colistin and rifampicin were 1-4 g/ml and 8-16 g/ml,
espectively. MIC50 and MIC90 of colistin were 1, 2 g/ml, respec-
ively and MIC50 and MIC90 of rifampicin were 8 g/ml. The
ynergy study showed the partial synergy effect of colistin when
ombined with rifampicin in 26.7% of the isolates. Bactericidal
ctivity of the combination was observed at all incubation times
y time-kill study. The more damaging effect of the bacterial cell
ysis was clearly observed when the bacteria were grown in the
ombined antimicrobials as compared with the growth in each
ntimicrobial agent.
Conclusion: The in vitro bactericidal activity of the combination
etween colistin and rifampicin was superior to the single agent.
he combination could be a promising alternative for the treatment
f infections due to carbapenem-resistant A. baumannii.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.584
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ntibiotic resistance proﬁles of Staphylococcus aureus blood-
tream isolates
. Prifti, A. Papanagiotou, A. Charalabopoulou, D. Samiotaki, S.
lachos, D. Togkas, E. Kostis ∗, K. Tzanetou
“Alexandra” General Hospital of Athens, Athens, Greece
Background: S. aureus is a common and serious cause of blood-
tream infections with high mortality rate.
Objective: To assess the resistance proﬁles of S. aureus blood-
tream isolates to commonly used antimicrobial agents.
Methods:We retrospectively evaluated all the cases of S. aureus
acteraemia over a two year period from October 2009 through
ctober 2011. Blood samples were routinely obtained in BacTec
ottles (aerobic and anaerobic) and incubated in BACTEC 9050
ystem. Coagulase production, detection of DNase activity onto
NA agar, API STAPH and automated MicroScan system were used
or Staphylococcus identiﬁcation. Antibiotic susceptibility testing
as performed by disc diffusion technique on Mueller-Hinton agar
ccording to CLSI recommendations and MICs were determined by
icroScan system and Etest (AB Biodisk, Solna, Sweden).
Results: During the study period 61 cases of S. aureus
acteraemia were identiﬁed. Of the total bloodstream isolates
6.07% (22/61) were found to be methicillin-resistant (MRSA),
nd 63.93% (39/61) methicillin-susceptible (MSSA). Extended
usceptibility testing of the 61 isolates to erythromycin, clin-
amycin, tetracycline, chloramphenicol, ciproﬂoxacin, rifampicin,
rimethoprim-sulphamethoxazole (SXT), gentamicin, vancomycin,
eicoplanin, linezolid and daptomycin showed the following resis-
ance rates: 72.73%, 68.18%, 63.63%, 18.18%, 63.63%, 0%, 4.54%,
8.18%, 9.09%, 0%, 0%, 0% forMRSAand12.82%, 7.69%, 12.82%, 2.56%,
.13%, 0%, 0%, 0%, 0%, 0%, 0%, 0% for MSSA respectively. Two of the
RSA bloodstream isolates (2/22) showed increased vancomycin
ICs (MICs =3 g/ml conﬁrmed by Etest) according to CLSI new
usceptibility breakpoint (MIC breakpoint for vancomycin has been
educed to 2 g/ml).fectious Diseases 16S (2012) e317–e473
Conclusion: (a) A signiﬁcant rate of S. aureus bloodstream iso-
lates is methicillin-resistant. (b) The MRSA isolates demonstrate
a high resistance rate to erythromycin, clindamycin, tetracycline
and ciproﬂoxacin, whereas a small proportion shows increased
vancomycinMICs. (c)MRSA blood isolates remain daptomycin sus-
ceptible, even with a vancomycin MIC >2 g/ml.
http://dx.doi.org/10.1016/j.ijid.2012.05.585
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Spectrum of causative agents of nosocomial infections (NI) and
their susceptibility to antimicrobials (AM) in multiward clinical
hospital: results of one-year surveillance study
R. Kozlov1,∗, S. Ratchina1, V. Mishchenko1, M. Sukhorukova1, O.
Kretchikova1, E. Korneva2, A. Kuleshov1, D. Gruzdova1
1 Smolensk State Medical Academy, Smolensk, Russian Federation
2 Smolensk regional clinical hospital, Smolensk, Russian Federation
Background: Continued surveillance of etiology and resistance
patterns, along with other measures is essential tool in decreas-
ing NI burden and proper resources allocation. Our study aimed to
determine the spectrumofmicrobial agents causingNI in Smolensk
regional clinical hospital and assess their susceptibility to com-
monly used AM.
Methods: All patients with conﬁrmed diagnosis of NI were
prospectively screened during 12 months period (November 2010-
October 2011). Routine culture and susceptibility testing was
performed for clinical samples by disk-diffusion method. Clinically
signiﬁcant mechanisms of resistance were detected by phenotypic
techniques (ESBLDDST,MBLDDST, cefoxitindisk). Appropriateness
of AM therapy was evaluated in accordance with local guidelines.
Results: A total of 128 patients with 134 NI episodes were
evaluated, etiology was determined in 41/134 (30.6%) of NI cases
(39 patients). Overall 67% of patients were male, mean age was
57.3 years. The most common HI were skin and soft tissue infec-
tions (56%), followed by respiratory tract (22%), urinary tract
(20%) and intraabdominal infections (2%). Seventy one pathogens
were isolated, the most common were the Enterobacteriaceae fam-
ily members – 23 (32.4%), including 15 (65.2%) ESBL producers,
Pseudomonas aeruginosa – 14 (19.7%), including 2 (14.3%) MBL pro-
ducers, Staphylococcus aureus – 11 (15.5%), including 10 (90.9%)
MRSA isolates,Acinetobacter spp.,mainlyAcinetobacter baumannii–
11 (15.5%), Enterococcus spp. – 8 (11.3%), other gram-negative non-
fermentative rods – 2 (2.8%), Streptococcus pyogenes – 1 (1.4%) and
Candida parapsilosis – 1 (1.4%). Empirical AM choice was appropri-
ate in 24% of cases. The regiment of AM therapy was adjusted on
receipt of culture results in 39% of patients and was consider as an
adequate in 54% of cases.
Conclusion: Gram negative rods, particularly Enterobacteri-
aceae and Pseudomonas aeruginosa represented the most common
causative agents of NI in Smolensk regional clinical hospital. High
prevalence of ESBL production andMRSA isolates causes grave con-revision of empirical AM therapy.
http://dx.doi.org/10.1016/j.ijid.2012.05.586
